Vanda Pharmaceuticals Ownership 2024 | Who Owns Vanda Pharmaceuticals Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

75.38%

Insider Ownership

3.16%

Retail Ownership

21.46%

Institutional Holders

152.00

Vanda Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.14.09%0.00%8,138,252-1,629-0.02%45,981,123Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC7.12%0.04%4,114,125-161,500-3.78%23,244,806Jun 30, 2024
VANGUARD GROUP INC5.94%0.00%3,431,67136,0881.06%19,388,941Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC3.73%1.24%2,153,307401,65322.93%12,166,185Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP3.49%0.00%2,013,807292,17216.97%11,378,664Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC3.43%0.03%1,982,027-388,308-16.38%11,194,000Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC2.76%0.53%1,593,516580,26557.27%9,003,365Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC2.57%0.03%1,486,26266,7024.70%8,397,380Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC2.30%0.00%1,330,95785,5756.87%7,521,707Jun 30, 2024
STATE STREET CORP2.10%0.00%1,211,3098,0140.67%6,843,896,000Jun 30, 2024
SCHRODER INVESTMENT MANAGEMENT GROUP2.00%0.01%1,155,4271,155,427100.00%6,528,163Jun 30, 2024
PRUDENTIAL FINANCIAL INC1.35%0.01%777,080-321,400-29.26%4,390,502Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.1.26%0.02%725,36632,4884.69%4,098,318Jun 30, 2024
FEDERATED HERMES, INC.1.24%0.01%715,645-25-0.00%4,043,394,000Jun 30, 2024
D. E. SHAW & CO., INC.1.20%0.00%692,736-1,110,106-61.58%3,913,959Jun 30, 2024
KRENSAVAGE ASSET MANAGEMENT, LLC1.15%1.72%662,166662,166100.00%3,741,000Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.03%0.00%592,737-75,443-11.29%3,348,964Jun 30, 2024
PROFIT INVESTMENT MANAGEMENT, LLC0.99%2.02%571,324351,000159.31%3,227,984Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC0.91%0.00%526,823224,17374.07%2,976,550Jun 30, 2024
MORGAN STANLEY0.86%0.00%497,220-1,011,428-67.04%2,809,294Jun 30, 2024

Vanda Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 14.09% of the company's total share outstanding, currently valued at $45.98M. The top 10 institutional shareholders own together 47.53% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PROFIT INVESTMENT MANAGEMENT, LLC0.99%2.02%571,324351,000159.31%3,227,984Jun 30, 2024
KRENSAVAGE ASSET MANAGEMENT, LLC1.15%1.72%662,166662,166100.00%3,741,000Jun 30, 2024
BML CAPITAL MANAGEMENT, LLC0.69%1.61%398,280398,280100.00%2,250,282Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC3.73%1.24%2,153,307401,65322.93%12,166,185Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC2.76%0.53%1,593,516580,26557.27%9,003,365Jun 30, 2024
STEAMBOAT CAPITAL PARTNERS, LLC0.17%0.21%100,000100,000100.00%565,000Jun 30, 2024
MONACO ASSET MANAGEMENT SAM0.33%0.17%192,926192,926100.00%1,090,032Jun 30, 2024
VIRTUS INVESTMENT ADVISERS, INC.0.05%0.14%28,25528,255100.00%159,641Jun 30, 2024
SCHULHOFF & CO INC0.07%0.10%38,500--217,525Jun 30, 2024
HUNTING HILL GLOBAL CAPITAL, LLC0.06%0.09%34,91634,916100.00%197,275Jun 30, 2024
DIAMETRIC CAPITAL, LP0.04%0.08%25,00025,000100.00%141,250Jun 30, 2024
CLEARALPHA TECHNOLOGIES LP0.07%0.07%40,00040,000100.00%226,000Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.76%0.06%437,963-88,420-16.80%2,474,491Jun 30, 2024
WINTON GROUP LTD0.20%0.04%113,483-50,343-30.73%641,179Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC7.12%0.04%4,114,125-161,500-3.78%23,244,806Jun 30, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC0.50%0.04%287,6775,9942.13%1,625,375Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC2.57%0.03%1,486,26266,7024.70%8,397,380Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC3.43%0.03%1,982,027-388,308-16.38%11,194,000Jun 30, 2024
CORNERCAP INVESTMENT COUNSEL INC0.06%0.03%32,561-334-1.02%183,970Jun 30, 2024
KENNEDY CAPITAL MANAGEMENT LLC0.40%0.03%229,065229,065100.00%1,294,217Jun 30, 2024

The largest Vanda Pharmaceuticals shareholder by % of total assets is PROFIT INVESTMENT MANAGEMENT, LLC. The company owns 571.32K shares of Vanda Pharmaceuticals (VNDA), representing 2.02% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SCHRODER INVESTMENT MANAGEMENT GROUP2.00%0.01%1,155,4271,155,427100.00%6,528,163Jun 30, 2024
KRENSAVAGE ASSET MANAGEMENT, LLC1.15%1.72%662,166662,166100.00%3,741,000Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC2.76%0.53%1,593,516580,26557.27%9,003,365Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC3.73%1.24%2,153,307401,65322.93%12,166,185Jun 30, 2024
BML CAPITAL MANAGEMENT, LLC0.69%1.61%398,280398,280100.00%2,250,282Jun 30, 2024
PROFIT INVESTMENT MANAGEMENT, LLC0.99%2.02%571,324351,000159.31%3,227,984Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP3.49%0.00%2,013,807292,17216.97%11,378,664Jun 30, 2024
KENNEDY CAPITAL MANAGEMENT LLC0.40%0.03%229,065229,065100.00%1,294,217Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC0.91%0.00%526,823224,17374.07%2,976,550Jun 30, 2024
MONACO ASSET MANAGEMENT SAM0.33%0.17%192,926192,926100.00%1,090,032Jun 30, 2024
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS0.30%0.01%175,000175,000100.00%988,750Jun 30, 2024
OMERS ADMINISTRATION CORP0.24%0.01%139,500139,500100.00%788,175Jun 30, 2024
JUMP FINANCIAL, LLC0.23%0.01%130,463130,463100.00%737,116Jun 30, 2024
NORGES BANK0.20%0.00%115,000115,000100.00%649,750Jun 30, 2024
STEAMBOAT CAPITAL PARTNERS, LLC0.17%0.21%100,000100,000100.00%565,000Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD0.17%0.00%99,73699,736100.00%563,508Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC2.30%0.00%1,330,95785,5756.87%7,521,707Jun 30, 2024
WOLVERINE TRADING, LLC0.14%0.00%81,20081,200100.00%458,780Jun 30, 2024
TREXQUANT INVESTMENT LP0.12%0.01%71,83471,834100.00%405,862Jun 30, 2024
GROUP ONE TRADING, L.P.0.16%0.00%94,25666,736242.50%532,546,000Jun 30, 2024

As of Jun 30 2024, Vanda Pharmaceuticals's largest institutional buyer is SCHRODER INVESTMENT MANAGEMENT GROUP. The company purchased 1.16M stocks of VNDA, valued at $6.53M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BANK OF AMERICA CORP /DE/0.13%-77,418-1,130,843-93.59%437,412Jun 30, 2024
D. E. SHAW & CO., INC.1.20%0.00%692,736-1,110,106-61.58%3,913,959Jun 30, 2024
MORGAN STANLEY0.86%0.00%497,220-1,011,428-67.04%2,809,294Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.----730,820-100.00%-Jun 30, 2024
GSA CAPITAL PARTNERS LLP----489,324-100.00%-Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.15%0.00%85,769-446,511-83.89%484,595Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.03%-16,237-416,565-96.25%91,739Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC3.43%0.03%1,982,027-388,308-16.38%11,194,000Jun 30, 2024
APG ASSET MANAGEMENT N.V.----371,900-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----370,246-100.00%-Jun 30, 2024
PRUDENTIAL FINANCIAL INC1.35%0.01%777,080-321,400-29.26%4,390,502Jun 30, 2024
NEWTYN MANAGEMENT, LLC----311,000-100.00%-Jun 30, 2024
VICTORY CAPITAL MANAGEMENT INC----216,717-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC7.12%0.04%4,114,125-161,500-3.78%23,244,806Jun 30, 2024
SQUAREPOINT OPS LLC0.14%0.00%79,030-156,573-66.46%446,520Jun 30, 2024
GOLDMAN SACHS GROUP INC0.62%0.00%356,546-148,839-29.45%2,014,485Jun 30, 2024
JPMORGAN CHASE & CO0.24%0.00%138,473-142,310-50.68%782,372Jun 30, 2024
TUDOR INVESTMENT CORP ET AL----139,040-100.00%-Jun 30, 2024
MASSACHUSETTS FINANCIAL SERVICES CO /MA/----136,340-100.00%-Jun 30, 2024
SEI INVESTMENTS CO0.68%0.00%395,157-123,694-23.84%2,232,637,000Jun 30, 2024

As of Jun 30 2024, Vanda Pharmaceuticals's biggest institutional seller is BANK OF AMERICA CORP /DE/. The company sold -1.13M shares of VNDA, valued at $437.41K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SCHRODER INVESTMENT MANAGEMENT GROUP2.00%0.01%1,155,4271,155,427100.00%6,528,163Jun 30, 2024
KRENSAVAGE ASSET MANAGEMENT, LLC1.15%1.72%662,166662,166100.00%3,741,000Jun 30, 2024
BML CAPITAL MANAGEMENT, LLC0.69%1.61%398,280398,280100.00%2,250,282Jun 30, 2024
KENNEDY CAPITAL MANAGEMENT LLC0.40%0.03%229,065229,065100.00%1,294,217Jun 30, 2024
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS0.30%0.01%175,000175,000100.00%988,750Jun 30, 2024
OMERS ADMINISTRATION CORP0.24%0.01%139,500139,500100.00%788,175Jun 30, 2024
NORGES BANK0.20%0.00%115,000115,000100.00%649,750Jun 30, 2024
STEAMBOAT CAPITAL PARTNERS, LLC0.17%0.21%100,000100,000100.00%565,000Jun 30, 2024
WOLVERINE TRADING, LLC0.14%0.00%81,20081,200100.00%458,780Jun 30, 2024
BANK OF MONTREAL /CAN/0.10%0.00%56,86156,861100.00%353,960Jun 30, 2024
CLEARALPHA TECHNOLOGIES LP0.07%0.07%40,00040,000100.00%226,000Jun 30, 2024
HUNTING HILL GLOBAL CAPITAL, LLC0.06%0.09%34,91634,916100.00%197,275Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.05%0.00%30,66730,667100.00%173,269Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.05%0.00%29,28629,286100.00%165,466Jun 30, 2024
VIRTUS INVESTMENT ADVISERS, INC.0.05%0.14%28,25528,255100.00%159,641Jun 30, 2024
DIAMETRIC CAPITAL, LP0.04%0.08%25,00025,000100.00%141,250Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC0.04%-24,08724,087100.00%136,092Jun 30, 2024
JBF CAPITAL, INC.0.03%0.02%20,00020,000100.00%113,000Jun 30, 2024
CENTIVA CAPITAL, LP0.03%0.00%17,80017,800100.00%100,570Jun 30, 2024
ATRIA INVESTMENTS, INC0.02%0.00%11,80611,806100.00%66,704Jun 30, 2024
WOLVERINE TRADING, LLC0.02%0.00%11,00011,000100.00%62,150Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD0.02%0.00%10,59410,594100.00%59,856Jun 30, 2024
MEEDER ASSET MANAGEMENT INC0.01%0.00%6,8526,852100.00%38,714Jun 30, 2024
HIGHTOWER ADVISORS, LLC0.01%-5,0005,000100.00%3,000Jun 30, 2024
CLEAR STREET MARKETS LLC0.01%0.00%4,1004,100100.00%23,000Jun 30, 2024
SRS CAPITAL ADVISORS, INC.0.00%0.00%1,9271,927100.00%10,888Jun 30, 2024
ORG PARTNERS LLC0.00%0.00%1,9231,923100.00%10,730,000Jun 30, 2024
FNY INVESTMENT ADVISERS, LLC0.00%0.00%1,0001,000100.00%5,000Jun 30, 2024
INNEALTA CAPITAL, LLC0.00%0.00%134134100.00%758Jun 30, 2024
TOTH FINANCIAL ADVISORY CORP0.00%0.00%9090100.00%509Jun 30, 2024
LINDBROOK CAPITAL, LLC0.00%-7373100.00%412Jun 30, 2024
SMARTLEAF ASSET MANAGEMENT LLC0.00%0.00%6767100.00%389Jun 30, 2024
PLANNING CAPITAL MANAGEMENT CORP--1010100.00%57Jun 30, 2024

Vanda Pharmaceuticals's largest new institutional shareholder by number of shares is SCHRODER INVESTMENT MANAGEMENT GROUP, purchased 1.16M shares, valued at $6.53M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ASSENAGON ASSET MANAGEMENT S.A.----730,820-100.00%-Jun 30, 2024
GSA CAPITAL PARTNERS LLP----489,324-100.00%-Jun 30, 2024
APG ASSET MANAGEMENT N.V.----371,900-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----370,246-100.00%-Jun 30, 2024
NEWTYN MANAGEMENT, LLC----311,000-100.00%-Jun 30, 2024
VICTORY CAPITAL MANAGEMENT INC----216,717-100.00%-Jun 30, 2024
TUDOR INVESTMENT CORP ET AL----139,040-100.00%-Jun 30, 2024
MASSACHUSETTS FINANCIAL SERVICES CO /MA/----136,340-100.00%-Jun 30, 2024
EMPIRE FINANCIAL MANAGEMENT COMPANY, LLC----65,000-100.00%-Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.----63,403-100.00%-Jun 30, 2024
OCCUDO QUANTITATIVE STRATEGIES LP----57,769-100.00%-Jun 30, 2024
MAN GROUP PLC----47,730-100.00%-Jun 30, 2024
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V.----40,547-100.00%-Jun 30, 2024
SHERBROOKE PARK ADVISERS LLC----39,229-100.00%-Jun 30, 2024
SHAY CAPITAL LLC----31,920-100.00%-Jun 30, 2024
HRT FINANCIAL LP----30,658-100.00%-Jun 30, 2024
THRIVENT FINANCIAL FOR LUTHERANS----30,009-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----27,841-100.00%-Jun 30, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.----27,045-100.00%-Jun 30, 2024
ENGINEERS GATE MANAGER LP----19,345-100.00%-Jun 30, 2024
WALLEYE CAPITAL LLC----19,018-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----18,529-100.00%-Jun 30, 2024
POINT72 (DIFC) LTD----16,301-100.00%-Jun 30, 2024
AIGEN INVESTMENT MANAGEMENT, LP----11,597-100.00%-Jun 30, 2024
STATE OF WYOMING----11,015-100.00%-Jun 30, 2024
RAYMOND JAMES & ASSOCIATES----10,000-100.00%-Jun 30, 2024
QUANTBOT TECHNOLOGIES LP----7,300-100.00%-Jun 30, 2024
HANTZ FINANCIAL SERVICES, INC.----1,500-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----1,471-100.00%-Jun 30, 2024
AQUATIC CAPITAL MANAGEMENT LLC----300-100.00%-Jun 30, 2024
COVESTOR LTD----286-100.00%-Jun 30, 2024
AVION WEALTH----140-100.00%-Jun 30, 2024
FIRST MANHATTAN CO. LLC.----100-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----10-100.00%-Jun 30, 2024

Vanda Pharmaceuticals's largest sold out institutional shareholder by shares sold is ASSENAGON ASSET MANAGEMENT S.A., sold -0.73M shares, valued at -, as of undefined.

Vanda Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
CORNERCAP GROUP OF FUNDS /VA/0.55%39,916--Sep 30, 2022
BlackRock Advantage SMID Cap Fund, Inc.0.34%64,97242,549189.76%Mar 28, 2024
Federated Hermes MDT Series0.27%675,517-151,278-18.30%Jan 31, 2024
VALUED ADVISERS TRUST0.21%196,538--Jan 31, 2024
SYNTAX ETF TRUST0.20%6,305--Mar 31, 2024
Vanguard Montgomery Funds0.15%36,773--Mar 31, 2024
SIT MUTUAL FUNDS INC0.15%55,350--Mar 28, 2024
BRIDGEWAY FUNDS INC0.14%325,100150,00085.67%Mar 28, 2024
VANGUARD ADMIRAL FUNDS0.09%394,677--Feb 29, 2024
ROYCE CAPITAL FUND0.09%33,177--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.08%41,986--Mar 31, 2024
BNY MELLON INDEX FUNDS, INC.0.07%72,787--Jan 31, 2024
Vericimetry Funds0.05%4,880--Mar 31, 2024
BNY MELLON INVESTMENT PORTFOLIOS0.05%30,627--Mar 31, 2024
SunAmerica Specialty Series0.05%25,822-2,103-7.53%Apr 30, 2021
360 Funds0.05%10,000--Feb 29, 2024
FRANKLIN VALUE INVESTORS TRUST0.05%176,800--Jan 31, 2024
HUSSMAN INVESTMENT TRUST0.04%156,000--Dec 31, 2023
DELAWARE GROUP EQUITY FUNDS V0.04%2,425,939--Feb 29, 2024
STATE STREET INSTITUTIONAL FUNDS0.04%32,400--Mar 31, 2024
AMERICAN CENTURY GROWTH FUNDS, INC.0.04%6,282--Jan 31, 2024
EXCHANGE TRADED CONCEPTS TRUST0.04%241,43611,3454.93%Feb 29, 2024
Humankind Benefit Corp0.04%887--Dec 31, 2023
PFM Multi-Manager Series Trust0.04%30,9162,0287.02%Dec 31, 2023
ETFis Series Trust I0.03%48,530--Jan 31, 2024
PRUDENTIAL INVESTMENT PORTFOLIOS 120.03%98,800--Jan 31, 2024
TARGET PORTFOLIO TRUST0.03%547,500130,10031.17%Jan 31, 2024
HOTCHKIS & WILEY FUNDS /DE/0.02%304,300--Mar 31, 2024
IndexIQ ETF Trust0.02%47,727-3,539-6.90%Jan 31, 2024
JAMES ADVANTAGE FUNDS0.02%43,517--Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.02%104,632--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%8,913--Mar 31, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.01%28,944--Mar 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.01%48,172--Mar 31, 2024
FORUM FUNDS II0.01%10,568--Jan 31, 2024
NUVEEN INVESTMENT FUNDS INC0.01%305,500--Jan 31, 2024
World Funds Trust0.01%104,784--Jan 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND0.01%84,293--Mar 31, 2024
SCHWAB CAPITAL TRUST0.01%349,144-7,106-1.99%Jan 31, 2024
VANGUARD HORIZON FUNDS0.01%190,345-306,999-61.73%Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%1,691--Mar 31, 2024
Fidelity Commonwealth Trust II0.01%46,697--Aug 31, 2023
JNL VARIABLE FUND LLC0.01%39,134--Mar 31, 2020
ROYCE VALUE TRUST, INC.0.01%5,100--Mar 31, 2024
VANGUARD INDEX FUNDS0.01%2,595,406-867,986-25.06%Mar 31, 2024
SSGA FUNDS0.01%2,392--Feb 29, 2024
Listed Funds Trust0.01%25,912--Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%22,100-27,300-55.26%Mar 31, 2024
VANGUARD EXPLORER FUND0.00%54,899--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%52,8645361.02%Mar 31, 2024
KINETICS PORTFOLIOS TRUST0.00%7,000--Mar 31, 2024
ADVISORS' INNER CIRCLE FUND0.00%94,500--Jan 31, 2024
Legg Mason ETF Investment Trust0.00%7,721--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%232,692--Feb 29, 2024
ALPS ETF Trust0.00%42,8322,2055.43%Feb 29, 2024
GPS Funds I0.00%18,379--Mar 31, 2024
FIDELITY COVINGTON TRUST0.00%58,192-674-1.14%Mar 31, 2024
PRUDENTIAL INVESTMENT PORTFOLIOS, INC.0.00%28,1771,0003.68%Mar 28, 2024
FIDELITY CONCORD STREET TRUST0.00%516,31831,9516.60%Feb 29, 2024
Lattice Strategies Trust0.00%3,738--Mar 31, 2024
ROYCE FUND0.00%16,016--Mar 31, 2024
PRAXIS MUTUAL FUNDS0.00%25,990--Dec 31, 2023
SHELTON FUNDS0.00%3,820--Feb 29, 2024
VANGUARD TAX-MANAGED FUNDS0.00%463,471--Mar 31, 2024
AMG Funds I0.00%4,365--Jan 31, 2024
AMG FUNDS III0.00%11,133--Mar 28, 2024
AMERICAN CENTURY ETF TRUST0.00%241,16119,1238.61%Feb 29, 2024
Principal Exchange-Traded Funds0.00%23,969--Mar 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%251,615--Mar 31, 2024
MFS VARIABLE INSURANCE TRUST III0.00%27,668-1,126-3.91%Mar 31, 2024
STEWARD FUNDS, INC.0.00%3,970--Jan 31, 2024
Calvert Variable Products, Inc.0.00%4,281--Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND VI0.00%7,778--Mar 31, 2024
OPTIMUM FUND TRUST0.00%62,100--Mar 28, 2024
Direxion Shares ETF Trust0.00%213,166--Jan 31, 2024
Victory Portfolios II0.00%68,957--Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%105,4761020.10%Jan 31, 2024
Dimensional ETF Trust0.00%557,611-127,754-18.64%Jan 31, 2024
CLEARWATER INVESTMENT TRUST0.00%11,943--Mar 28, 2024
Columbia Funds Variable Series Trust II0.00%38,282--Mar 31, 2024
TIMOTHY PLAN0.00%5,594--Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%1,217,557211,82321.06%Jan 31, 2024
Guggenheim Variable Funds Trust0.00%4,646--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%34,519-2,645-7.12%Mar 31, 2024
Catholic Responsible Investments Funds0.00%36,487--Jan 31, 2024
VICTORY PORTFOLIOS0.00%27,820--Mar 31, 2024
MASTER INVESTMENT PORTFOLIO0.00%79,93024,74744.85%Mar 31, 2024
PRUDENTIAL SERIES FUND0.00%65,511--Mar 28, 2024
VANGUARD WORLD FUND0.00%197,7179920.50%Feb 29, 2024
OHIO NATIONAL FUND INC0.00%15,755--Mar 31, 2024
Managed Portfolio Series0.00%16,101--Mar 31, 2024
BMO FUNDS, INC.0.00%27,450-3,028-9.94%Nov 30, 2021
PUTNAM ASSET ALLOCATION FUNDS0.00%19,981--Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%2,958--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%18,875-5,757-23.37%Mar 31, 2024
Global X Funds0.00%26,160--Jan 31, 2024
Mutual of America Variable Insurance Portfolios, Inc.0.00%416--Sep 30, 2023
Horizon Funds0.00%1,104--Feb 29, 2024
SCHWAB STRATEGIC TRUST0.00%304,83210,8303.68%Feb 29, 2024
FINANCIAL INVESTORS TRUST0.00%41,094--Jan 31, 2024

Vanda Pharmaceuticals's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 39.92K shares, compromising 0.55% of its total assets.

Vanda Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 241524.11%
31 Mar, 24146-8.18%
31 Dec, 23159-13.11%
30 Sep, 23183-3.68%
30 Jun, 231905.56%
31 Mar, 23180-6.25%
31 Dec, 221927.26%
30 Sep, 221792.87%
30 Jun, 22174-8.42%
31 Mar, 22190-9.52%
31 Dec, 2121012.90%
30 Sep, 211860.54%
30 Jun, 21185-2.63%
31 Mar, 211906.74%
31 Dec, 201786.59%
30 Sep, 201670.60%
30 Jun, 201661.84%
31 Mar, 20163-11.89%
31 Dec, 1918510.12%
30 Sep, 19168-
30 Jun, 19168-9.68%
31 Mar, 19186-6.06%
31 Dec, 1819816.47%
30 Sep, 1817019.72%
30 Jun, 181420.71%
31 Mar, 181412.92%
31 Dec, 17137-8.05%
30 Sep, 171496.43%
30 Jun, 17140-2.78%
31 Mar, 17144-8.28%
31 Dec, 16157-1.26%
30 Sep, 1615924.22%
30 Jun, 161282.40%
31 Mar, 16125-0.79%
31 Dec, 15126-5.26%
30 Sep, 151339.02%
30 Jun, 15122-2.40%
31 Mar, 151250.81%
31 Dec, 141245.98%
30 Sep, 14117-7.14%
30 Jun, 141260.80%
31 Mar, 1412513.64%
31 Dec, 13110-6.78%
30 Sep, 1311819.19%
30 Jun, 1399219.35%
31 Mar, 133110.71%
31 Dec, 122812.00%
30 Sep, 1225-19.35%
30 Jun, 123110.71%
31 Mar, 1228-15.15%
31 Dec, 113343.48%
30 Sep, 1123-14.81%
30 Jun, 1127-10.00%
31 Mar, 113020.00%
31 Dec, 102513.64%
30 Sep, 1022-15.38%
30 Jun, 1026-7.14%
31 Mar, 1028-6.67%
31 Dec, 09307.14%
30 Sep, 092816.67%
30 Jun, 0924200.00%
31 Mar, 098-38.46%
31 Dec, 0813-27.78%
30 Sep, 081812.50%
30 Jun, 0816-15.79%
31 Mar, 0819-5.00%
31 Dec, 0720-
30 Sep, 072033.33%
30 Jun, 0715150.00%
31 Mar, 076-33.33%
31 Dec, 069350.00%
30 Sep, 062-
30 Mar, 061-

As of 30 Jun 24, 152 institutions are holding Vanda Pharmaceuticals's shares, representing an increase of 4.11% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2443,538,402-9.37%
31 Mar, 2448,037,922-4.96%
31 Dec, 2350,545,253-3.66%
30 Sep, 2352,465,300-6.73%
30 Jun, 2356,249,200-3.53%
31 Mar, 2358,309,1865.05%
31 Dec, 2255,507,2840.81%
30 Sep, 2255,059,370-1.69%
30 Jun, 2256,007,273-0.47%
31 Mar, 2256,273,3383.79%
31 Dec, 2154,216,368-1.74%
30 Sep, 2155,176,1190.71%
30 Jun, 2154,786,6140.53%
31 Mar, 2154,496,294-1.03%
31 Dec, 2055,062,4221.29%
30 Sep, 2054,360,563-1.33%
30 Jun, 2055,094,4971.98%
31 Mar, 2054,026,7192.21%
31 Dec, 1952,858,334-0.18%
30 Sep, 1952,951,542-2.44%
30 Jun, 1954,277,444-0.18%
31 Mar, 1954,377,8152.58%
31 Dec, 1853,011,6891.54%
30 Sep, 1852,208,0156.50%
30 Jun, 1849,022,6371.70%
31 Mar, 1848,202,70317.93%
31 Dec, 1740,872,8572.89%
30 Sep, 1739,724,8452.23%
30 Jun, 1738,857,178-2.14%
31 Mar, 1739,705,272-2.30%
31 Dec, 1640,641,946-0.29%
30 Sep, 1640,758,9509.43%
30 Jun, 1637,247,873-9.72%
31 Mar, 1641,259,778-3.00%
31 Dec, 1542,534,512-0.51%
30 Sep, 1542,751,0900.80%
30 Jun, 1542,413,658-8.56%
31 Mar, 1546,382,606-2.69%
31 Dec, 1447,666,26715.37%
30 Sep, 1441,316,3047.36%
30 Jun, 1438,482,2479.45%
31 Mar, 1435,160,00810.96%
31 Dec, 1331,688,098-1.16%
30 Sep, 1332,059,40240.89%
30 Jun, 1322,754,669126.39%
31 Mar, 1310,050,95537.55%
31 Dec, 127,307,14225.92%
30 Sep, 125,803,155-9.42%
30 Jun, 126,406,4916.12%
31 Mar, 126,036,9150.77%
31 Dec, 115,991,059-8.98%
30 Sep, 116,582,2173.25%
30 Jun, 116,375,311-32.45%
31 Mar, 119,437,80839.94%
31 Dec, 106,743,9674.79%
30 Sep, 106,435,895-2.05%
30 Jun, 106,570,779-27.20%
31 Mar, 109,026,29517.30%
31 Dec, 097,694,79688.52%
30 Sep, 094,081,606132.48%
30 Jun, 091,755,66815.36%
31 Mar, 091,521,871-62.84%
31 Dec, 084,095,948-27.45%
30 Sep, 085,645,87974.79%
30 Jun, 083,230,159-8.13%
31 Mar, 083,516,034-31.10%
31 Dec, 075,102,788-13.58%
30 Sep, 075,904,382188.92%
30 Jun, 072,043,57847.50%
31 Mar, 071,385,4394.96%
31 Dec, 061,319,915-46.05%
30 Sep, 062,446,749-
30 Mar, 062,700-

Vanda Pharmaceuticals (VNDA) has 43.54M shares outstanding as of 30 Jun 24, down -9.37% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2475.38%1.09%
31 Mar, 2483.17%1.08%
31 Dec, 2387.86%1.06%
30 Sep, 2391.21%0.95%
30 Jun, 2397.90%0.94%
31 Mar, 23102.28%1.07%
31 Dec, 2297.98%1.03%
30 Sep, 2297.32%0.99%
30 Jun, 2299.11%0.99%
31 Mar, 22100.30%1.05%
31 Dec, 2197.60%0.99%
30 Sep, 2199.12%1.02%
30 Jun, 2198.57%1.01%
31 Mar, 2198.82%0.99%
31 Dec, 2099.85%1.01%
30 Sep, 2099.44%0.97%
30 Jun, 20101.09%1.00%
31 Mar, 20100.41%1.02%
31 Dec, 1999.00%1.00%
30 Sep, 1999.35%0.95%
30 Jun, 19102.21%0.96%
31 Mar, 19103.08%1.01%
31 Dec, 18101.06%1.02%
30 Sep, 1899.65%1.13%
30 Jun, 1893.96%0.87%
31 Mar, 18104.03%1.23%
31 Dec, 1791.90%1.17%
30 Sep, 1788.50%1.17%
30 Jun, 1786.89%1.09%
31 Mar, 1789.43%1.02%
31 Dec, 1693.54%1.07%
30 Sep, 1693.67%1.26%
30 Jun, 1686.22%0.94%
31 Mar, 1695.72%0.94%
31 Dec, 15100.67%0.99%
30 Sep, 15100.74%0.99%
30 Jun, 15101.01%0.82%
31 Mar, 15111.11%0.69%
31 Dec, 14126.69%0.85%
30 Sep, 14121.92%0.94%
30 Jun, 14113.60%1.04%
31 Mar, 14104.40%1.15%
31 Dec, 1395.21%0.91%
30 Sep, 13102.32%1.59%
30 Jun, 1380.19%6.38%
31 Mar, 1335.46%5.29%
31 Dec, 1225.89%6.04%
30 Sep, 1220.70%4.02%
30 Jun, 1222.70%4.96%
31 Mar, 1221.39%4.71%
31 Dec, 1121.32%3.89%
30 Sep, 1123.42%4.55%
30 Jun, 1122.69%2.01%
31 Mar, 1133.58%5.83%
31 Dec, 1024.00%4.54%
30 Sep, 1022.98%4.14%
30 Jun, 1023.55%2.22%
31 Mar, 1032.58%4.02%
31 Dec, 0928.48%12.65%
30 Sep, 0915.01%35.23%
30 Jun, 096.53%20.02%
31 Mar, 095.71%2.42%
31 Dec, 0815.37%3.42%
30 Sep, 0821.18%14.42%
30 Jun, 0812.12%6.96%
31 Mar, 0813.19%3.60%
31 Dec, 0719.15%3.89%
30 Sep, 0722.19%37.50%
30 Jun, 077.69%25.73%
31 Mar, 075.47%8.04%
31 Dec, 068.25%6.59%
30 Sep, 0611.19%-
30 Mar, 060.01%-

As of 30 Jun 24, Vanda Pharmaceuticals is held by 75.38% institutional shareholders, representing a 1.09% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 248329.69%
31 Mar, 2464-20.99%
31 Dec, 2381-10.99%
30 Sep, 2391-7.14%
30 Jun, 239812.64%
31 Mar, 2387-17.14%
31 Dec, 221059.38%
30 Sep, 229621.52%
30 Jun, 2279-3.66%
31 Mar, 2282-22.64%
31 Dec, 2110635.90%
30 Sep, 2178-10.34%
30 Jun, 2187-14.71%
31 Mar, 2110217.24%
31 Dec, 20877.41%
30 Sep, 2081-3.57%
30 Jun, 20843.70%
31 Mar, 2081-8.99%
31 Dec, 1989-11.88%
30 Sep, 1910118.82%
30 Jun, 1985-24.78%
31 Mar, 191130.89%
31 Dec, 1811219.15%
30 Sep, 189434.29%
30 Jun, 18707.69%
31 Mar, 18651.56%
31 Dec, 1764-11.11%
30 Sep, 17729.09%
30 Jun, 1766-
31 Mar, 1766-17.50%
31 Dec, 1680-13.98%
30 Sep, 169375.47%
30 Jun, 1653-1.85%
31 Mar, 1654-3.57%
31 Dec, 1556-24.32%
30 Sep, 157427.59%
30 Jun, 1558-6.45%
31 Mar, 1562-12.68%
31 Dec, 147161.36%
30 Sep, 1444-26.67%
30 Jun, 1460-11.76%
31 Mar, 146825.93%
31 Dec, 1354-26.03%
30 Sep, 1373-1.35%
30 Jun, 1374311.11%
31 Mar, 131812.50%
31 Dec, 121623.08%
30 Sep, 1213-27.78%
30 Jun, 121850.00%
31 Mar, 1212-45.45%
31 Dec, 1122175.00%
30 Sep, 118-20.00%
30 Jun, 1110-44.44%
31 Mar, 111820.00%
31 Dec, 1015150.00%
30 Sep, 106-70.00%
30 Jun, 102011.11%
31 Mar, 1018-14.29%
31 Dec, 092131.25%
30 Sep, 0916-15.79%
30 Jun, 0919850.00%
31 Mar, 092-60.00%
31 Dec, 085-58.33%
30 Sep, 081250.00%
30 Jun, 088-20.00%
31 Mar, 0810-23.08%
31 Dec, 0713-
30 Sep, 071318.18%
30 Jun, 0711120.00%
31 Mar, 075-28.57%
31 Dec, 067250.00%
30 Sep, 062-
30 Mar, 061-

83 institutional shareholders have increased their position in VNDA stock as of 30 Jun 24 compared to 64 in the previous quarter (a 29.69% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2446-20.69%
31 Mar, 24585.45%
31 Dec, 2355-17.91%
30 Sep, 23679.84%
30 Jun, 2361-1.61%
31 Mar, 236219.23%
31 Dec, 2252-
30 Sep, 2252-10.34%
30 Jun, 2258-23.68%
31 Mar, 227613.43%
31 Dec, 2167-6.94%
30 Sep, 217220.00%
30 Jun, 2160-4.76%
31 Mar, 21633.28%
31 Dec, 206110.91%
30 Sep, 20551.85%
30 Jun, 20548.00%
31 Mar, 2050-28.57%
31 Dec, 197059.09%
30 Sep, 1944-20.00%
30 Jun, 195527.91%
31 Mar, 1943-28.33%
31 Dec, 186039.53%
30 Sep, 1843-2.27%
30 Jun, 1844-2.22%
31 Mar, 18454.65%
31 Dec, 17434.88%
30 Sep, 1741-10.87%
30 Jun, 1746-16.36%
31 Mar, 175510.00%
31 Dec, 165056.25%
30 Sep, 1632-23.81%
30 Jun, 16427.69%
31 Mar, 163914.71%
31 Dec, 153413.33%
30 Sep, 1530-18.92%
30 Jun, 153712.12%
31 Mar, 153326.92%
31 Dec, 1426-29.73%
30 Sep, 1437-7.50%
30 Jun, 144025.00%
31 Mar, 143228.00%
31 Dec, 132531.58%
30 Sep, 1319111.11%
30 Jun, 139-10.00%
31 Mar, 131011.11%
31 Dec, 129125.00%
30 Sep, 124-60.00%
30 Jun, 121011.11%
31 Mar, 12928.57%
31 Dec, 117-36.36%
30 Sep, 1111-
30 Jun, 111137.50%
31 Mar, 11814.29%
31 Dec, 107-41.67%
30 Sep, 1012100.00%
30 Jun, 106-
31 Mar, 106200.00%
31 Dec, 092-66.67%
30 Sep, 096200.00%
30 Jun, 092-
31 Mar, 092-50.00%
31 Dec, 084300.00%
30 Sep, 081-80.00%
30 Jun, 085-16.67%
31 Mar, 086200.00%
31 Dec, 072-
30 Sep, 072100.00%
30 Jun, 071-
31 Mar, 07--100.00%
31 Dec, 062-
30 Sep, 06--
30 Mar, 06--

46 institutional shareholders have reduced their position in VNDA stock as of 30 Jun 24 compared to 58 in the previous quarter (a -20.69% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 241524.11%43,538,402-9.37%75.38%1.09%8329.69%46-20.69%
31 Mar, 24146-8.18%48,037,922-4.96%83.17%1.08%64-20.99%585.45%
31 Dec, 23159-13.11%50,545,253-3.66%87.86%1.06%81-10.99%55-17.91%
30 Sep, 23183-3.68%52,465,300-6.73%91.21%0.95%91-7.14%679.84%
30 Jun, 231905.56%56,249,200-3.53%97.90%0.94%9812.64%61-1.61%
31 Mar, 23180-6.25%58,309,1865.05%102.28%1.07%87-17.14%6219.23%
31 Dec, 221927.26%55,507,2840.81%97.98%1.03%1059.38%52-
30 Sep, 221792.87%55,059,370-1.69%97.32%0.99%9621.52%52-10.34%
30 Jun, 22174-8.42%56,007,273-0.47%99.11%0.99%79-3.66%58-23.68%
31 Mar, 22190-9.52%56,273,3383.79%100.30%1.05%82-22.64%7613.43%
31 Dec, 2121012.90%54,216,368-1.74%97.60%0.99%10635.90%67-6.94%
30 Sep, 211860.54%55,176,1190.71%99.12%1.02%78-10.34%7220.00%
30 Jun, 21185-2.63%54,786,6140.53%98.57%1.01%87-14.71%60-4.76%
31 Mar, 211906.74%54,496,294-1.03%98.82%0.99%10217.24%633.28%
31 Dec, 201786.59%55,062,4221.29%99.85%1.01%877.41%6110.91%
30 Sep, 201670.60%54,360,563-1.33%99.44%0.97%81-3.57%551.85%
30 Jun, 201661.84%55,094,4971.98%101.09%1.00%843.70%548.00%
31 Mar, 20163-11.89%54,026,7192.21%100.41%1.02%81-8.99%50-28.57%
31 Dec, 1918510.12%52,858,334-0.18%99.00%1.00%89-11.88%7059.09%
30 Sep, 19168-52,951,542-2.44%99.35%0.95%10118.82%44-20.00%
30 Jun, 19168-9.68%54,277,444-0.18%102.21%0.96%85-24.78%5527.91%
31 Mar, 19186-6.06%54,377,8152.58%103.08%1.01%1130.89%43-28.33%
31 Dec, 1819816.47%53,011,6891.54%101.06%1.02%11219.15%6039.53%
30 Sep, 1817019.72%52,208,0156.50%99.65%1.13%9434.29%43-2.27%
30 Jun, 181420.71%49,022,6371.70%93.96%0.87%707.69%44-2.22%
31 Mar, 181412.92%48,202,70317.93%104.03%1.23%651.56%454.65%
31 Dec, 17137-8.05%40,872,8572.89%91.90%1.17%64-11.11%434.88%
30 Sep, 171496.43%39,724,8452.23%88.50%1.17%729.09%41-10.87%
30 Jun, 17140-2.78%38,857,178-2.14%86.89%1.09%66-46-16.36%
31 Mar, 17144-8.28%39,705,272-2.30%89.43%1.02%66-17.50%5510.00%
31 Dec, 16157-1.26%40,641,946-0.29%93.54%1.07%80-13.98%5056.25%
30 Sep, 1615924.22%40,758,9509.43%93.67%1.26%9375.47%32-23.81%
30 Jun, 161282.40%37,247,873-9.72%86.22%0.94%53-1.85%427.69%
31 Mar, 16125-0.79%41,259,778-3.00%95.72%0.94%54-3.57%3914.71%
31 Dec, 15126-5.26%42,534,512-0.51%100.67%0.99%56-24.32%3413.33%
30 Sep, 151339.02%42,751,0900.80%100.74%0.99%7427.59%30-18.92%
30 Jun, 15122-2.40%42,413,658-8.56%101.01%0.82%58-6.45%3712.12%
31 Mar, 151250.81%46,382,606-2.69%111.11%0.69%62-12.68%3326.92%
31 Dec, 141245.98%47,666,26715.37%126.69%0.85%7161.36%26-29.73%
30 Sep, 14117-7.14%41,316,3047.36%121.92%0.94%44-26.67%37-7.50%
30 Jun, 141260.80%38,482,2479.45%113.60%1.04%60-11.76%4025.00%
31 Mar, 1412513.64%35,160,00810.96%104.40%1.15%6825.93%3228.00%
31 Dec, 13110-6.78%31,688,098-1.16%95.21%0.91%54-26.03%2531.58%
30 Sep, 1311819.19%32,059,40240.89%102.32%1.59%73-1.35%19111.11%
30 Jun, 1399219.35%22,754,669126.39%80.19%6.38%74311.11%9-10.00%
31 Mar, 133110.71%10,050,95537.55%35.46%5.29%1812.50%1011.11%
31 Dec, 122812.00%7,307,14225.92%25.89%6.04%1623.08%9125.00%
30 Sep, 1225-19.35%5,803,155-9.42%20.70%4.02%13-27.78%4-60.00%
30 Jun, 123110.71%6,406,4916.12%22.70%4.96%1850.00%1011.11%
31 Mar, 1228-15.15%6,036,9150.77%21.39%4.71%12-45.45%928.57%
31 Dec, 113343.48%5,991,059-8.98%21.32%3.89%22175.00%7-36.36%
30 Sep, 1123-14.81%6,582,2173.25%23.42%4.55%8-20.00%11-
30 Jun, 1127-10.00%6,375,311-32.45%22.69%2.01%10-44.44%1137.50%
31 Mar, 113020.00%9,437,80839.94%33.58%5.83%1820.00%814.29%
31 Dec, 102513.64%6,743,9674.79%24.00%4.54%15150.00%7-41.67%
30 Sep, 1022-15.38%6,435,895-2.05%22.98%4.14%6-70.00%12100.00%
30 Jun, 1026-7.14%6,570,779-27.20%23.55%2.22%2011.11%6-
31 Mar, 1028-6.67%9,026,29517.30%32.58%4.02%18-14.29%6200.00%
31 Dec, 09307.14%7,694,79688.52%28.48%12.65%2131.25%2-66.67%
30 Sep, 092816.67%4,081,606132.48%15.01%35.23%16-15.79%6200.00%
30 Jun, 0924200.00%1,755,66815.36%6.53%20.02%19850.00%2-
31 Mar, 098-38.46%1,521,871-62.84%5.71%2.42%2-60.00%2-50.00%
31 Dec, 0813-27.78%4,095,948-27.45%15.37%3.42%5-58.33%4300.00%
30 Sep, 081812.50%5,645,87974.79%21.18%14.42%1250.00%1-80.00%
30 Jun, 0816-15.79%3,230,159-8.13%12.12%6.96%8-20.00%5-16.67%
31 Mar, 0819-5.00%3,516,034-31.10%13.19%3.60%10-23.08%6200.00%
31 Dec, 0720-5,102,788-13.58%19.15%3.89%13-2-
30 Sep, 072033.33%5,904,382188.92%22.19%37.50%1318.18%2100.00%
30 Jun, 0715150.00%2,043,57847.50%7.69%25.73%11120.00%1-
31 Mar, 076-33.33%1,385,4394.96%5.47%8.04%5-28.57%--100.00%
31 Dec, 069350.00%1,319,915-46.05%8.25%6.59%7250.00%2-
30 Sep, 062-2,446,749-11.19%-2---
30 Mar, 061-2,700-0.01%-1---

Vanda Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 29, 2024Moran Kevin Patrickofficer SVP, CFO & TreasurerS-SaleSell2,251$5.92$13.33K228,763
Mar 06, 2024Williams Timothyofficer SVP & General CounselS-SaleSell8,147$4.41$35.92K205,766
Mar 06, 2024Williams Timothyofficer SVP & General CounselS-SaleSell8,941$4.18$37.40K196,825
Mar 06, 2024Wijkstrom Joakimofficer SVP, Chief Marketing OfficerS-SaleSell7,498$4.41$33.09K139,018
Mar 06, 2024Wijkstrom Joakimofficer SVP, Chief Marketing OfficerS-SaleSell9,229$4.21$38.83K129,789
Mar 06, 2024Polymeropoulos Mihael Hristosdirector, officer, other President and CEOS-SaleSell30,884$4.24$131.07K1,896,018
Mar 06, 2024Polymeropoulos Mihael Hristosdirector, officer, other President and CEOS-SaleSell24,288$4.13$100.27K1,871,730
Mar 06, 2024Moran Kevin Patrickofficer SVP, CFO & TreasurerS-SaleSell5,798$4.48$25.98K239,916
Mar 06, 2024Moran Kevin Patrickofficer SVP, CFO & TreasurerS-SaleSell8,902$4.20$37.41K231,014
Mar 06, 2024Birznieks Guntherofficer SVP, Business DevelopmentS-SaleSell8,727$4.30$37.49K322,253

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 29, 2024Moran Kevin Patrickofficer SVP, CFO & TreasurerS-SaleSell2,251$5.92$13.33K228,763
Mar 06, 2024Williams Timothyofficer SVP & General CounselS-SaleSell8,147$4.41$35.92K205,766
Mar 06, 2024Williams Timothyofficer SVP & General CounselS-SaleSell8,941$4.18$37.40K196,825
Mar 06, 2024Wijkstrom Joakimofficer SVP, Chief Marketing OfficerS-SaleSell7,498$4.41$33.09K139,018
Mar 06, 2024Wijkstrom Joakimofficer SVP, Chief Marketing OfficerS-SaleSell9,229$4.21$38.83K129,789
Mar 06, 2024Polymeropoulos Mihael Hristosdirector, officer, other President and CEOS-SaleSell30,884$4.24$131.07K1,896,018
Mar 06, 2024Polymeropoulos Mihael Hristosdirector, officer, other President and CEOS-SaleSell24,288$4.13$100.27K1,871,730
Mar 06, 2024Moran Kevin Patrickofficer SVP, CFO & TreasurerS-SaleSell5,798$4.48$25.98K239,916
Mar 06, 2024Moran Kevin Patrickofficer SVP, CFO & TreasurerS-SaleSell8,902$4.20$37.41K231,014
Mar 06, 2024Birznieks Guntherofficer SVP, Business DevelopmentS-SaleSell8,727$4.30$37.49K322,253

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 29, 2024Moran Kevin Patrickofficer SVP, CFO & TreasurerS-SaleSell2,251$5.92$13.33K228,763
May 24, 2024Chrousos Phaedradirector-A-AwardBuy21,887--64,125
May 24, 2024Chrousos Phaedradirector-A-AwardBuy40,202$5.14$206.64K40,202
May 21, 2024Honore Tagedirector-A-AwardBuy20,529--64,244
May 21, 2024Honore Tagedirector-A-AwardBuy37,578$5.48$205.93K37,578
May 21, 2024DUGAN RICHARD Wdirector-A-AwardBuy20,529--118,229
May 21, 2024DUGAN RICHARD Wdirector-A-AwardBuy37,578$5.48$205.93K37,578
May 21, 2024Mitchell Stephen Raydirector-A-AwardBuy20,529--49,857
May 21, 2024Mitchell Stephen Raydirector-A-AwardBuy37,578$5.48$205.93K37,578
May 21, 2024Ward Anne Sempowskidirector-A-AwardBuy20,529--59,842
May 21, 2024Ward Anne Sempowskidirector-A-AwardBuy37,578$5.48$205.93K37,578
Mar 06, 2024Williams Timothyofficer SVP & General CounselS-SaleSell8,147$4.41$35.92K205,766
Mar 06, 2024Williams Timothyofficer SVP & General CounselS-SaleSell8,941$4.18$37.40K196,825
Mar 06, 2024Wijkstrom Joakimofficer SVP, Chief Marketing OfficerS-SaleSell7,498$4.41$33.09K139,018
Mar 06, 2024Wijkstrom Joakimofficer SVP, Chief Marketing OfficerS-SaleSell9,229$4.21$38.83K129,789
Mar 06, 2024Polymeropoulos Mihael Hristosdirector, officer, other President and CEOS-SaleSell30,884$4.24$131.07K1,896,018
Mar 06, 2024Polymeropoulos Mihael Hristosdirector, officer, other President and CEOS-SaleSell24,288$4.13$100.27K1,871,730
Mar 06, 2024Moran Kevin Patrickofficer SVP, CFO & TreasurerS-SaleSell5,798$4.48$25.98K239,916
Mar 06, 2024Moran Kevin Patrickofficer SVP, CFO & TreasurerS-SaleSell8,902$4.20$37.41K231,014
Mar 06, 2024Birznieks Guntherofficer SVP, Business DevelopmentS-SaleSell8,727$4.30$37.49K322,253

The last insider sell of Vanda Pharmaceuticals's stock was made by Moran Kevin Patrick on Jul 29 2024, selling 2,251 shares at $5.92 per share (valued at $13.33K).

Vanda Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-1-
Q2 202410--
Q1 202451050.00%
Q3 2023-4-
Q2 2023102500.00%
Q1 20231210120.00%
Q4 20223742.86%
Q3 20221616.67%
Q2 2022124300.00%
Q1 2022108125.00%
Q4 20212450.00%
Q3 202141040.00%
Q2 2021113366.67%
Q1 2021162176.19%
Q4 20203650.00%
Q3 20202450.00%
Q2 2020124300.00%
Q1 2020112347.83%
Q4 20193475.00%
Q3 20193560.00%

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Vanda Pharmaceuticals's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-1-
Q2 2024---
Q1 2024-10-
Q3 2023-4-
Q2 2023-2-
Q1 2023-10-
Q4 2022-4-
Q3 2022-4-
Q2 2022-3-
Q1 2022-8-
Q4 2021-2-
Q3 2021-6-
Q2 2021-2-
Q1 2021-17-
Q4 2020-3-
Q3 2020-4-
Q2 2020-2-
Q1 2020-13-
Q4 2019-2-
Q3 2019-2-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Vanda Pharmaceuticals's stocks.

Vanda Pharmaceuticals Peer Ownership


TickerCompany
NUVBNuvation Bio Inc.
CGEMCullinan Oncology, Inc.
RVMDRevolution Medicines, Inc. Warrant
RCUSArcus Biosciences, Inc.
BPMCBlueprint Medicines Corporation
PHATPhathom Pharmaceuticals, Inc.
STOKStoke Therapeutics, Inc.
BMRNBioMarin Pharmaceutical Inc.
TSVT2seventy bio, Inc.
RLAYRelay Therapeutics, Inc.
REPLReplimune Group, Inc.
LEGNLegend Biotech Corporation
GRPHLENZ Therapeutics, Inc.
CNTBConnect Biopharma Holdings Limited
ANNXAnnexon, Inc.
GPCRStructure Therapeutics Inc.
LQDALiquidia Corporation
PCVXVaxcyte, Inc.
NLTXNeurogene Inc.
KZRKezar Life Sciences, Inc.
CYTKCytokinetics, Incorporated
TECHBio-Techne Corporation
TILInstil Bio, Inc.

VNDA Ownership FAQ


Vanda Pharmaceuticals is owned by institutional shareholders (75.38%), insiders (3.16%), and public (21.46%). The largest institutional shareholder of Vanda Pharmaceuticals is BLACKROCK INC. (14.09% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.55% of total shares).

Vanda Pharmaceuticals's major institutional shareholders are BLACKROCK INC., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, and DIMENSIONAL FUND ADVISORS LP. The top five shareholders own together 34.37% of the company's share outstanding.

As of Jun 2024, there are 152 institutional shareholders of Vanda Pharmaceuticals.

BLACKROCK INC owns 8.14M shares of Vanda Pharmaceuticals, representing 14.09% of the company's total shares outstanding, valued at $45.98M (as of Jun 2024).

As of Jun 2024, RENAISSANCE TECHNOLOGIES LLC holds 4.11M shares of Vanda Pharmaceuticals (VNDA), compromising 7.12% of the company, valued at $23.24M.

VANGUARD GROUP INC is the third largest holder of Vanda Pharmaceuticals. The company owns 3.43M of the company's shares outstanding (worth $19.39M).